These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 4372543

  • 1. Antigenic inhibition of cell-mediated cytotoxicity against tumour cells.
    Shellam GR, Knight RA.
    Nature; 1974 Nov 22; 252(5481):330-2. PubMed ID: 4372543
    [No Abstract] [Full Text] [Related]

  • 2. Antigenic expression as a determining factor of tumor growth in Gross' virus lymphoma.
    Ioachim HL, Keller S, Sabbath M, Dorsett B.
    Prog Exp Tumor Res; 1974 Nov 22; 19():284-96. PubMed ID: 4373783
    [No Abstract] [Full Text] [Related]

  • 3. Antigenic characteristics of murine leukemia induced by chemical carcinogens.
    Colnaghi MI, Della Porta G.
    Bibl Haematol; 1973 Nov 22; 39():595-602. PubMed ID: 4591438
    [No Abstract] [Full Text] [Related]

  • 4. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses.
    Ferrer JF.
    Int J Cancer; 1973 Sep 15; 12(2):378-88. PubMed ID: 4134124
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunogenicity of tumor antigens.
    Herberman RB, Campbell DA, Oldham RK, Bonnard GD, Ting CC, Holden HT, Glaser M, Djeu J, Oehler R.
    Ann N Y Acad Sci; 1976 Sep 15; 276():26-44. PubMed ID: 194517
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M, Kedar E, Fahey JL.
    J Immunol; 1974 Jun 15; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract] [Full Text] [Related]

  • 9. Tumor cell-related syngeneic skin graft rejection in gross leukemia.
    Mariani T, Maruyama Y, Good RA.
    Natl Cancer Inst Monogr; 1972 Dec 15; 35():309-20. PubMed ID: 4572830
    [No Abstract] [Full Text] [Related]

  • 10. Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.
    Kedar E, Otiz de Landazuri M, Fahey JL.
    J Immunol; 1974 Jan 15; 112(1):26-36. PubMed ID: 4812174
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J.
    Ser Haematol; 1972 Jan 15; 5(4):93-122. PubMed ID: 4133765
    [No Abstract] [Full Text] [Related]

  • 14. Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma.
    Ioachim HL, Keller SE, Dorsett BH, Pearse A.
    J Exp Med; 1974 Jun 01; 139(6):1382-94. PubMed ID: 4208416
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F, Levy JP.
    Nature; 1974 May 17; 249(454):271-4. PubMed ID: 4545403
    [No Abstract] [Full Text] [Related]

  • 18. Transplantability, immunological unresponsiveness, and loss of cellular antigenicity in gross virus lymphoma.
    Ioachim HL, Keller SE, Dorsett BH.
    Bibl Haematol; 1975 May 17; (40):301-10. PubMed ID: 51627
    [Abstract] [Full Text] [Related]

  • 19. Immune response to Gross virus-induced lymphoma: comparison of two in vitro assays of cell-mediated immunity.
    Wright PW, Ortiz de Landazuri M, Herberman RB.
    J Natl Cancer Inst; 1973 Apr 17; 50(4):947-54. PubMed ID: 4574190
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.